论文部分内容阅读
肛门癌是韩国特有的罕见临床疾病,但还没有一个拥有足够人数的生存率分析。全北大学的Park HC等人利用韩国中央癌症登记处1993~2010年期间的2 552份病历进行了5年相对生存率的评估,发现肛门癌患者的5年相对生存率从1993~1995年的38.9%提高到2006~2010年的65.6%;肛管鳞状细胞癌最常见,且比其他癌症生存率高;女性的生存率在所有阶段都比男性高;40岁前、后的生存率分别为62.4%及52.6%。研究结果显示,韩国肛门癌具有鲜明的性别、年龄及
Anal cancer is a rare clinical disease endemic to Korea, but there is not yet a survival analysis with a sufficient number of people. Park HC et al. At Jeonbuk University conducted a 5-year relative survival assessment using 2 552 medical records from Korea Central Registry of Cancer during 1993-2010 and found that the 5-year relative survival rate of patients with anal cancer increased from 1993 to 1995 38.9% to 65.6% from 2006 to 2010; anal canal squamous cell carcinoma is the most common and has a higher survival rate than other cancers; the survival rate of women is higher than that of men at all stages; At 62.4% and 52.6% respectively. The results show that Korean anal cancer has a distinctive gender, age and